PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.54%
Revenue growth under 50% of MAXN's 17.45%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-0.76%
Negative gross profit growth while MAXN is at 227.56%. Joel Greenblatt would examine cost competitiveness or demand decline.
-91.91%
Negative EBIT growth while MAXN is at 69.31%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
76.66%
Operating income growth 1.25-1.5x MAXN's 69.31%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
-94.39%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-94.87%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-94.44%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.06%
Share reduction more than 1.5x MAXN's 9.97%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-8.82%
Reduced diluted shares while MAXN is at 9.97%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-119.63%
Negative OCF growth while MAXN is at 199.35%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-13.53%
Negative FCF growth while MAXN is at 157.60%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-50.04%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-39.49%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-27.93%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-105.61%
Negative 10Y OCF/share CAGR while MAXN stands at 179.61%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-119.42%
Negative 5Y OCF/share CAGR while MAXN is at 179.61%. Joel Greenblatt would question the firm’s operational model or cost structure.
-341.68%
Negative 3Y OCF/share CAGR while MAXN stands at 179.61%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
103.58%
Positive 10Y CAGR while MAXN is negative. John Neff might see a substantial advantage in bottom-line trajectory.
101.07%
Positive 5Y CAGR while MAXN is negative. John Neff might view this as a strong mid-term relative advantage.
22.42%
Positive short-term CAGR while MAXN is negative. John Neff would see a clear advantage in near-term profit trajectory.
-60.55%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
222.10%
Positive 5Y equity/share CAGR while MAXN is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
4848.85%
Positive short-term equity growth while MAXN is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while MAXN stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
5.03%
Our AR growth while MAXN is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
38.80%
Inventory growth well above MAXN's 0.79%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
3.64%
Asset growth above 1.5x MAXN's 0.31%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.53%
Positive BV/share change while MAXN is negative. John Neff sees a clear edge over a competitor losing equity.
1.70%
Debt growth far above MAXN's 1.21%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-18.04%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-5.70%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.